CompletedNCT04015869
Allopregnanolone for Stress-Related Craving and Anxiety
About this title
Read the official source — NCT04015869Medication studyAges 21–50United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 21 years to 50 years.
- Listed locations
- West HavenSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Study information
Study start dateStarted: July 1, 2019
- Recruitment status
- Completed
- Enrollment listed in the registry
- 10
- Sponsor
- Yale University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 21 Years to 50 Years
- Official registry ID
- NCT04015869
- Official title
Show the full official title
Effect of Allopregnanolone on Stress-induced Craving
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
West Haven
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Yale University, a university.
Did this study involve medication?
Yes. The study involved medication, including Allopregnanolone and Placebos.
Who was this study for?
Listed age limits: 21 years to 50 years.
